Description
Docemaps 120mg Injection is a medication containing the active ingredient Docetaxel. Docetaxel is a potent chemotherapy drug that belongs to the taxane class of antineoplastic agents. It works by interfering with the normal function of microtubules, which are essential components of cell division. By disrupting microtubule assembly and disassembly, Docetaxel effectively halts the proliferation of rapidly dividing cancer cells, leading to their death. This mechanism makes it a valuable treatment for various types of cancer. Docemaps 120mg Injection is indicated for the treatment of specific types of cancer, including breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer. The dosage and administration of Docemaps 120mg Injection should be strictly determined by a qualified healthcare professional based on the patient’s individual condition, the type and stage of cancer, and their response to treatment. Common side effects may include bone marrow suppression (leading to low blood cell counts), hair loss, fatigue, nausea, vomiting, diarrhea, and peripheral neuropathy. It is crucial to report any adverse reactions to your doctor promptly. Docemaps 120mg Injection should be stored at room temperature (20°C to 25°C or 68°F to 77°F), protected from light, and should not be refrigerated or frozen. It is administered intravenously by a healthcare professional.
